Stay updated with breaking news from Monitoring Challenges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
THIS PAGE WILL BE UPDATED WITH THE LATEST NEWS UPDATE: 1:00 PM CET Regime is Heading Towards Economic Collapse, Economist Warns Hossein Raghfar, a
According to a report by the research center of the Iranian regime’s parliament, due to "poverty among families," the number of child laborers has increased to 15 percent of the population of childr